![Neil McFarlane](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Neil McFarlane
Amministratore Delegato presso
ZEVRA THERAPEUTICS, INC.
Patrimonio netto: 4 M $ in data 31/05/2026
Profilo
Neil F.
McFarlane is President, Chief Executive Officer & Director at Zevra Therapeutics, Inc. since 2023.
Former roles include Chief Executive Officer at Adamas Pharmaceuticals LLC from 2019 to 2021, Independent Director at Collegium Pharmaceutical, Inc. from 2022 to 2024, Vice President & General Manager at UCB, Inc. from 2011 to 2016, and Chief Operating Officer at Travere Therapeutics, Inc. from 2016 to 2019.
Education includes undergraduate and graduate degrees from the University of Florida.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 06/04/2026 | 304.282 ( 0,51% ) | 4 M $ | 31/05/2026 |
Posizioni attive di Neil McFarlane
| Società | Posizione | Inizio |
|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Amministratore Delegato | 10/10/2023 |
Precedenti posizioni note di Neil McFarlane
| Società | Posizione | Fine |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Direttore/Membro del Consiglio | 28/07/2024 |
| ADAMAS PHARMACEUTICALS, INC. | Amministratore Delegato | 01/11/2021 |
| TRAVERE THERAPEUTICS, INC. | Direttore operativo | 31/05/2019 |
UCB, Inc.
 UCB, Inc. Financial ConglomeratesFinance Provides financial services | Corporate Officer/Principal | 01/01/2016 |
Formazione di Neil McFarlane
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
20
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Collegium Pharmaceutical, Inc.
 Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Zevra Therapeutics, Inc.
 Zevra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets proprietary prodrugs | Health Technology |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | Finance |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
